dc.contributor.author |
Kanishk, Dang |
|
dc.date.accessioned |
2020-11-22T16:18:11Z |
|
dc.date.available |
2020-11-22T16:18:11Z |
|
dc.date.issued |
2020-10 |
|
dc.identifier.uri |
https://stiinta.usmf.md/ro/manifestari-stiintifice/zilele-universitatii |
|
dc.identifier.uri |
http://repository.usmf.md/handle/20.500.12710/13154 |
|
dc.description |
Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină și Farmacie „Nicolae Testemițanu” din Republica Moldova, Ziua internațională a științei pentru pace și dezvoltare |
en_US |
dc.description.abstract |
Introduction:
• SARS-CoV-2 is a declared pandemic and health
threat.
• Previously identified SARS-CoV and MERS-CoV
from the same Betacoronavirus genus had
neurological implications.
Purpose:
To emphasize relationship between neurological
comorbidities and SARS-CoV-2 and management.
Material and methods:
A systematic review of PubMed and ResearchGate
articles using the mentioned keywords.
Results:
One-tenth of patients with existing neurological
comorbidities develop SARS-CoV-2.
Conclusions:
• Neurological comorbidities increased
susceptibility and presented in SARS-CoV-2.
• Differentiate existing comorbidities and SARS-CoV-2 to avoid misdiagnosis.
• Develop individualized plan to maintain
treatment and prevent exacerbation. |
en_US |
dc.language.iso |
en |
en_US |
dc.publisher |
Universitatea de Stat de Medicină şi Farmacie "Nicolae Testemiţanu" |
en_US |
dc.subject |
SARS-CoV-2 |
en_US |
dc.subject |
coronavirus |
en_US |
dc.subject |
neurology |
en_US |
dc.subject |
comorbidities |
en_US |
dc.subject |
2019-nCoV |
en_US |
dc.title |
Neurological comorbidities in patients with severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) |
en_US |
dc.type |
Working Paper |
en_US |